Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A Yardley, M.D.
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Cancer Specialists North
Fort Myers, Florida, United States
- Florida Cancer Specialists South
Fort Myers, Florida, United States
- Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
- Florida Hospital Cancer Insitute
Orlando, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Mercy Hospital
Portland, Maine, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- National Capital Clinical Research Consortium
Bethesda, Maryland, United States
- Nebraska Methodist Cancer Center
Omaha, Nebraska, United States
- Atlantic Health System
Morristown, New Jersey, United States
- Hematology Oncology Associates of Northern Nj
Morristown, New Jersey, United States
- Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
- Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Texas Health Physician Group
Arlington, Texas, United States
- the Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Sept 2011
- Primary completion
- 3 Apr 2017
- Completion
- 3 Apr 2017
- Last update posted
- 15 Jun 2018
- Registered enrollment
- 127
- Registry id
- NCT01401959
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.